Figure 1. Targeting CSCs to effectively treat cancer.
The inability of conventional therapies to target CSCs represents a significant factor contributing to current cancer treatment failure. A combination of conventional therapy and CSC-specific therapy is expected to achieve a better clinical outcome by inhibiting tumor regrowth mediated by drug-resistant CSCs.